{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:21:19Z","timestamp":1760548879854,"version":"3.37.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/fpc.0b013e3283307cba","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T17:49:42Z","timestamp":1258652982000},"page":"911-922","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacogenetic association study of 30 genes with phenobarbital drug response in epileptic dogs"],"prefix":"10.1097","volume":"19","author":[{"given":"Erin M.","family":"Kennerly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Idaghdour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha J.","family":"Olby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R.","family":"Munana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-1-20210214","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2460\/javma.1995.206.11.1721","article-title":"Seizure classification in dogs from a nonreferral-based population","volume":"206","author":"Podell","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"R3-1-20210214","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1939-1676.1999.tb02159.x","article-title":"Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology","volume":"13","author":"Berendt","year":"1999","journal-title":"J Vet Intern Med"},{"key":"R4-1-20210214","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1525-5050(02)00523-1","article-title":"Clinical presentations of naturally occurring canine seizures: similarities to human seizures","volume":"3","author":"Licht","year":"2002","journal-title":"Epilepsy Behav"},{"key":"R5-1-20210214","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tvjl.2005.07.001","article-title":"Canine epilepsy: what we can learn from human seizure disorders?","volume":"172","author":"Chandler","year":"2006","journal-title":"Vet J"},{"key":"R6-1-20210214","first-page":"3","article-title":"Pharamacokinetics: dynamics of drug absorption, distribution, and elimination","volume":"9","author":"Benet","year":"1996","journal-title":"Pharmacol Basic Ther"},{"key":"R7-1-20210214","first-page":"724","article-title":"Management of canine epilepsy with phenobarbital and potassium bromide","volume":"35","author":"Dowling","year":"1994","journal-title":"Can Vet J"},{"key":"R8-1-20210214","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2885.1985.tb00934.x","article-title":"Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison","volume":"8","author":"Schwartz-Porsche","year":"1985","journal-title":"J Vet Pharmacol Ther"},{"key":"R9-1-20210214","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1528-1157.2001.19400.x","article-title":"Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components","volume":"42","author":"Cramer","year":"2001","journal-title":"Epilepsia"},{"key":"R10-1-20210214","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2460\/javma.1998.213.10.1449","article-title":"Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992\u20131996)","volume":"213","author":"Trepanier","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"R11-1-20210214","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1939-1676.1993.tb01025.x","article-title":"Bromide therapy in refractory canine idiopathic epilepsy","volume":"7","author":"Poddell","year":"1993","journal-title":"J Vet Intern Med"},{"key":"R12-1-20210214","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1354\/vp.42-2-147","article-title":"Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital","volume":"42","author":"Gaskill","year":"2005","journal-title":"Vet Pathol"},{"key":"R13-1-20210214","first-page":"681","article-title":"Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants","volume":"212","author":"Jacobs","year":"1998","journal-title":"JAMA"},{"key":"R14-1-20210214","first-page":"319","article-title":"Clinical characteristics an inheritance of idiopathic epilepsy in Vizslas","volume":"17","author":"Patterson","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"R15-1-20210214","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2460\/javma.2005.226.54","article-title":"Clinical description and mode of inheritance of idiopathic epilepsy in English Springer Spaniels","volume":"226","author":"Patterson","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"R16-1-20210214","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1748-5827.1998.tb03650.x","article-title":"Genetic aspects of idiopathic epilepsy in Labrador retrievers","volume":"39","author":"Jaggy","year":"1998","journal-title":"J Small Anim Pract"},{"key":"R17-1-20210214","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1939-1676.2006.tb02832.x","article-title":"Epilepsy in Irish wolfhounds","volume":"20","author":"Casal","year":"2006","journal-title":"J Intern Vet Med"},{"key":"R18-1-20210214","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1073\/pnas.0407346102","article-title":"Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin","volume":"102","author":"Tate","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-1-20210214","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1073\/pnas.0402374101","article-title":"Breed distribution and history of canine mdrl-l Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage","volume":"101","author":"Neff","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-1-20210214","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"},{"key":"R21-1-20210214","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"key":"R22-1-20210214","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies","volume":"11","author":"Armitage","year":"1955","journal-title":"Biometrics"},{"key":"R23-1-20210214","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2307\/2533494","article-title":"From genotype to genes: doubling the sample size","volume":"53","author":"Sasieni","year":"1997","journal-title":"Biometrics"},{"key":"R24-1-20210214","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S0016672399004231","article-title":"A classical setting for associations between markers and loci affecting quantitative traits","volume":"74","author":"Nielsen","year":"1999","journal-title":"Genet Res"},{"key":"R25-1-20210214","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1086\/302959","article-title":"Association mapping in structured populations","volume":"67","author":"Pritchard","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R26-1-20210214","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/genetics\/164.4.1567","article-title":"Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies","volume":"164","author":"Faulsh","year":"2003","journal-title":"Genetics"},{"key":"R27-1-20210214","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1097406","article-title":"Genetic structure of the purebred domestic dog","volume":"304","author":"Parker","year":"2004","journal-title":"Science"},{"key":"R28-1-20210214","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/302449","article-title":"Use of unlinked genetic markers to detect population stratification in association studies","volume":"65","author":"Pritchard","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R29-1-20210214","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","article-title":"Genetic power calculator: design of linkage and association genetic mapping studies of complex traits","volume":"19","author":"Purcell","year":"2003","journal-title":"Bioinformatics"},{"key":"R30-1-20210214","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1101\/gr.3147604","article-title":"Extensive and breed-specific linkage disequilibrium in Canis familiaris","volume":"14","author":"Sutter","year":"2004","journal-title":"Genome Res"},{"key":"R31-1-20210214","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2460\/javma.1988.193.09.1131","article-title":"Research on genetic diseases: reciprocal benefits to animals and man","volume":"193","author":"Patterson","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"R32-1-20210214","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00134-003-1761-8","article-title":"A reader's guide to the interpretation of diagnostic test properties: clinical example of sepsis","volume":"29","author":"Fischer","year":"2003","journal-title":"Intensive Care Med"},{"key":"R33-1-20210214","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","article-title":"Principles and practical application of the receiver-operating characteristics analysis for diagnostic test","volume":"45","author":"Greiner","year":"2000","journal-title":"Prev Vet Med"},{"key":"R35-1-20210214","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.1137045","article-title":"A single IGF1 allele is a major determinant of small size in dogs","volume":"316","author":"Sutter","year":"2007","journal-title":"Science"},{"key":"R36-1-20210214","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2007.10","article-title":"Efficient mapping of Mendelian traits in dogs through genome-wide association","volume":"39","author":"Karlsson","year":"2007","journal-title":"Nat Genet"},{"key":"R37-1-20210214","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"R38-1-20210214","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2174\/1381612054021006","article-title":"Ion channels and epilepsy","volume":"11","author":"Armijo","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R39-1-20210214","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/1252","article-title":"Febrile seizures and generalized epilepsy associated with a mutation in the Na(+)-channel beta-1 subunit gene SCN1B","volume":"19","author":"Wallace","year":"1998","journal-title":"Nat Genet"},{"key":"R40-1-20210214","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/WNL.57.4.703","article-title":"Na-v-1.1 mutations cause febrile seizures associated with afebrile partial seizures","volume":"57","author":"Sugawara","year":"2001","journal-title":"Neurology"},{"key":"R41-1-20210214","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.wnl.0000317090.92185.ec","article-title":"KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes","volume":"72","author":"NeuBauer","year":"2008","journal-title":"Neurology"},{"key":"R42-1-20210214","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nbd.2005.09.006","article-title":"Anti-epileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABAA receptor ligand binding in a model of temporal lobe epilepsy","volume":"21","author":"Volk","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R43-1-20210214","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2008.01.005","article-title":"Antiepileptic drug resistant rats differ from drug responsive rats in GABAA receptor subunit expression in a model of temporal lobe epilepsy","volume":"31","author":"Bethmann","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R44-1-20210214","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"R45-1-20210214","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: proof of principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R46-1-20210214","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2460\/javma.1984.184.09.1117","article-title":"Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy","volume":"184","author":"Farnback","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"R47-1-20210214","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1096-2867(98)80035-2","article-title":"Idiopathic epilepsy","volume":"13","author":"Knowles","year":"1998","journal-title":"Clin Tech Small Anim Pract"},{"key":"R48-1-20210214","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003088-200746040-00001","article-title":"The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications","volume":"46","author":"Klutz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R49-1-20210214","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00498250412331285436","article-title":"Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion","volume":"34","author":"Tenmizu","year":"2004","journal-title":"Xenobiotica"},{"key":"R50-1-20210214","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj2810577","article-title":"Phenobarbital induction of cytochrome P-450 gene expression","volume":"281","author":"Waxman","year":"1992","journal-title":"Biochem J"},{"key":"R51-1-20210214","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2131\/jts.33.307","article-title":"Blood coagulation-related parameter changes in Sprague-Dawley (SD) rats treated with phenobarbital (PB) and PB plus vitamin K","volume":"33","author":"Mochizuki","year":"2008","journal-title":"J Toxicol Sci"},{"key":"R52-1-20210214","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clpt.2005.01.010","article-title":"Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome p450 2C9","volume":"77","author":"Loebstein","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R53-1-20210214","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.63.10_suppl_4.S3","article-title":"Pharmacogenetics and enzyme induction\/inhibition properties of antiepileptic drugs","volume":"63","author":"Anderson","year":"2004","journal-title":"Neurology"},{"key":"R54-1-20210214","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FTD.0b013e318030def0","article-title":"Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese","volume":"29","author":"Goto","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R55-1-20210214","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jbt.20118","article-title":"Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes","volume":"20","author":"Graham","year":"2006","journal-title":"J Biochem Mol Toxicol"},{"key":"R56-1-20210214","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1748-5827.2006.00203.x","article-title":"Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and\/or potassium bromide","volume":"47","author":"Chang","year":"2006","journal-title":"J Small Anim Pract"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200912000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:42:28Z","timestamp":1739439748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200912000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e3283307cba","relation":{},"ISSN":["1744-6872"],"issn-type":[{"type":"print","value":"1744-6872"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}